$ Value
—
Shares
8,333
Price
—
Filed
Sep 3
Insider
Name
Smalling Ralph
Title
Head of Regulatory
CIK
0001983288
Roles
Transaction Details
Transaction Date
2025-09-01
Code
D
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common Stock upon vesting. The RSUs will vest 25% on the first anniversary of the grant date, and the remaining shares will vest in 12 equal quarterly (every 3 months) installments thereafter. | The shares subject to the option vest as follows: 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter. | The transactions reported herein reflect a one-time reduction of the exercise price of the stock option, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration date or the vesting schedule of the stock option.
Filing Info
Smalling Ralph's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-25 | GNLX | ▼ | $602 |
| 2026-03-24 | GNLX | ▼ | $835 |
| 2025-12-05 | GNLX | ▼ | $774 |
| 2025-11-17 | GNLX | ▼ | $2K |
| 2025-09-03 | GNLX | ▼ | $2K |
| 2025-09-01 | GNLX | A | $0 |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
| 2025-08-27 | GNLX | A | $0 |
| 2025-08-27 | GNLX | A | $0 |
Other Insiders at GNLX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Yu Yong / Cappello Joseph
SVP, Clinical Development
|
— | $2K | 2026-03-24 |
|
Zindrick Thomas
President and CEO
|
— | $9K | 2026-03-24 |
| Thomas John | — | $29K | 2026-03-02 |
|
Smalling Ralph
Head of Regulatory
|
— | $1K | 2026-03-25 |